Literature DB >> 25092222

A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.

Junko Arakawa1,2, Akira Hamabe3,4, Takeshi Aiba5, Tomoo Nagai3,4, Mikoto Yoshida3,4, Takumi Touya3,4, Norio Ishigami3,4, Hideki Hisadome4, Shuichi Katsushika3,4, Hirotsugu Tabata3,4, Yoshihiro Miyamoto6, Wataru Shimizu5,7.   

Abstract

Sudden cardiac death (SCD) in athletes <35 years of age are mostly due to congenital or acquired cardiac malformations or hypertrophic cardiomyopathy. However, ion channelopathies such as catecholaminergic polymorphic ventricular tachycardia (CPVT) or long-QT syndromes, which are less frequently observed, are also potential pathogenesis of SCD in young athletes. CPVT is an inherited arrhythmia that is induced by physical or emotional stress and may lead to ventricular fibrillation syncope or SCD. Here, we report a case of athlete woman with adult-onset CPVT and aborted SCD who has a novel missense mutation (K4392R) in the cardiac RyR2 gene.

Entities:  

Keywords:  Cardiac ryanodine receptor; Catecholaminergic polymorphic ventricular tachycardia; Sudden cardiac death

Mesh:

Substances:

Year:  2014        PMID: 25092222     DOI: 10.1007/s00380-014-0555-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

1.  Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

Authors:  Barry J Maron; Paul D Thompson; Michael J Ackerman; Gary Balady; Stuart Berger; David Cohen; Robert Dimeff; Pamela S Douglas; David W Glover; Adolph M Hutter; Michael D Krauss; Martin S Maron; Matthew J Mitten; William O Roberts; James C Puffer
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

2.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian van der Werf; Prince J Kannankeril; Frederic Sacher; Andrew D Krahn; Sami Viskin; Antoine Leenhardt; Wataru Shimizu; Naokata Sumitomo; Frank A Fish; Zahurul A Bhuiyan; Albert R Willems; Maurits J van der Veen; Hiroshi Watanabe; Julien Laborderie; Michel Haïssaguerre; Björn C Knollmann; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

3.  A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium.

Authors:  Albano C Meli; Marwan M Refaat; Miroslav Dura; Steven Reiken; Anetta Wronska; Julianne Wojciak; Joan Carroll; Melvin M Scheinman; Andrew R Marks
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

4.  The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Authors:  Jane Caldwell; Natalie Moreton; Naz Khan; Lauren Kerzin-Storrar; Kay Metcalfe; William Newman; Clifford J Garratt
Journal:  Heart       Date:  2012-04       Impact factor: 5.994

5.  Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Raymond W Sy; Michael H Gollob; George J Klein; Raymond Yee; Allan C Skanes; Lorne J Gula; Peter Leong-Sit; Robert M Gow; Martin S Green; David H Birnie; Andrew D Krahn
Journal:  Heart Rhythm       Date:  2011-02-09       Impact factor: 6.343

6.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  H Lahat; E Pras; T Olender; N Avidan; E Ben-Asher; O Man; E Levy-Nissenbaum; A Khoury; A Lorber; B Goldman; D Lancet; M Eldar
Journal:  Am J Hum Genet       Date:  2001-10-25       Impact factor: 11.025

7.  The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease.

Authors:  Aya Miyazaki; Heima Sakaguchi; Hideo Ohuchi; Kenji Yasuda; Nobuyuki Tsujii; Michio Matsuoka; Tetsuya Yamamoto; Satoshi Yazaki; Etsuko Tsuda; Osamu Yamada
Journal:  Heart Vessels       Date:  2013-11-27       Impact factor: 2.037

8.  Genetic characterization of familial CPVT after 30 years.

Authors:  Theresa A Beery; Maully J Shah; D Woodrow Benson
Journal:  Biol Res Nurs       Date:  2009-04-26       Impact factor: 2.522

Review 9.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

10.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.

Authors:  Hiroshi Watanabe; Nagesh Chopra; Derek Laver; Hyun Seok Hwang; Sean S Davies; Daniel E Roach; Henry J Duff; Dan M Roden; Arthur A M Wilde; Björn C Knollmann
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

View more
  5 in total

1.  Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene.

Authors:  Yuki Taniguchi; Aya Miyazaki; Heima Sakaguchi; Yousuke Hayama; Norihiro Ebishima; Jun Negishi; Kanae Noritake; Yoshihiro Miyamoto; Wataru Shimizu; Takeshi Aiba; Hideo Ohuchi
Journal:  Heart Vessels       Date:  2016-07-11       Impact factor: 2.037

2.  Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2.

Authors:  Nagomi Kurebayashi; Takashi Murayama; Ryosaku Ota; Fumiyoshi Yamashita; Junji Suzuki; Kazunori Kanemaru; Takuya Kobayashi; Seiko Ohno; Minoru Horie; Masamitsu Iino; Takashi Sakurai
Journal:  J Gen Physiol       Date:  2022-04-21       Impact factor: 4.000

Review 3.  Genetics of inherited primary arrhythmia disorders.

Authors:  Danna A Spears; Michael H Gollob
Journal:  Appl Clin Genet       Date:  2015-09-18

4.  A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease.

Authors:  Boglárka Marcsa; Réka Dénes; Krisztina Vörös; Gergely Rácz; Mária Sasvári-Székely; Zsolt Rónai; Klára Törő; Gergely Keszler
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 5.  Novel approaches for the treatment of ventricular tachycardia.

Authors:  Michael Spartalis; Eleftherios Spartalis; Eleni Tzatzaki; Diamantis I Tsilimigras; Demetrios Moris; Christos Kontogiannis; Efthimios Livanis; Dimitrios C Iliopoulos; Vassilis Voudris; George N Theodorakis
Journal:  World J Cardiol       Date:  2018-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.